New data independently confirms and extends laboratory findings and expands safety profile of ATH434 August 4, 2020August 4, 2020
FDA Approval to Commence Huntington’s Disease Clinical Trial Using Prana’s PBT2: Huntington Study Group appointed to coordinate the trial and start recruitment July 17, 2013
